Attention must be paid to determining how extreme risk protection order laws can best be used with special populations such ...
Current National Institutes of Health (NIH) policy allows corporations to commercialize medical technologies with few ...
In a new book review, Senior Editor Margaret Winchester reviews “Crowded Out: The True Costs of Crowdfunding Healthcare” by ...
The stable share of GDP devoted to health care reported in 2023 NHE data masks important underlying trends: Commercial prices ...
New Medicare standards have introduced changes that are intended to benefit dual-eligible individuals through increased ...
Health care spending in the US reached $4.9 trillion and increased 7.5 percent in 2023, growing from a rate of 4.6 percent in 2022. In 2023, the insured share of the population reached 92.5 percent, ...
Given the dangerous consequences of system failure, health care leaders must support programs and systems that focus on resiliency and continuity planning to mitigate these hazards.
CMS has aggressive 2030 goals to transform how care is provided by moving patients and providers toward accountable models of ...
Devices that are approved through a process that does not require any clinical evidence for FDA authorization should not ...
A new analysis from the Office of the Actuary at the Centers for Medicare & Medicaid Services (CMS)—published online today by ...
Caremark, Express Scripts, and OptumRx continue to defend themselves against a Federal Trade Commission administrative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback